Literature DB >> 9677207

Intravenous beta blockade in acute myocardial infarction. Should be used in combination with thrombolysis.

A Owen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9677207      PMCID： PMC1113582          DOI： 10.1136/bmj.317.7153.226

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  Trial of early nifedipine in acute myocardial infarction: the Trent study.

Authors:  R G Wilcox; J R Hampton; D C Banks; J S Birkhead; I A Brooksby; C J Burns-Cox; M J Hayes; M D Joy; A D Malcolm; H G Mather
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-08

Review 2.  Adjunctive drug therapy of acute myocardial infarction--evidence from clinical trials.

Authors:  C H Hennekens; C M Albert; S L Godfried; J M Gaziano; J E Buring
Journal:  N Engl J Med       Date:  1996-11-28       Impact factor: 91.245

3.  Large-scale trials of thrombolytic therapy for acute myocardial infarction: GISSI-2, ISIS-3, and GUSTO-1.

Authors:  P M Ridker; C O'Donnell; V J Marder; C H Hennekens
Journal:  Ann Intern Med       Date:  1993-09-15       Impact factor: 25.391

4.  [Atenolol i.v. in the acute phase of AMI: the indications, contraindications and interactions with thrombolytic drugs in the GISSI-2 study. The GISSI-2 Researchers. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].

Authors:  A Mafrici; F Mauri; A P Maggioni; M G Franzosi; L Santoro; C De Vita
Journal:  G Ital Cardiol       Date:  1995-03

5.  Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial.

Authors:  A Hjalmarson; D Elmfeldt; J Herlitz; S Holmberg; I Málek; G Nyberg; L Rydén; K Swedberg; A Vedin; F Waagstein; A Waldenström; J Waldenström; H Wedel; L Wilhelmsen; C Wilhelmsson
Journal:  Lancet       Date:  1981-10-17       Impact factor: 79.321

6.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1993-09-02       Impact factor: 91.245

7.  Occurrence of hypotension during streptokinase infusion in suspected acute myocardial infarction, and its relation to prognosis and metoprolol therapy.

Authors:  J Herlitz; M Hartford; S Aune; T Karlsson
Journal:  Am J Cardiol       Date:  1993-05-01       Impact factor: 2.778

8.  GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.

Authors: 
Journal:  Lancet       Date:  1990-07-14       Impact factor: 79.321

9.  Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1986-07-12       Impact factor: 79.321

Review 10.  Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1994-02-05       Impact factor: 79.321
View more
  2 in total

1.  Intravenous beta blockade in acute myocardial infarction. Doubts exist about external validity of trials of intravenous beta blockade.

Authors:  K L Woods; D Ketley
Journal:  BMJ       Date:  1999-01-30

2.  beta Blockade after myocardial infarction: systematic review and meta regression analysis.

Authors:  N Freemantle; J Cleland; P Young; J Mason; J Harrison
Journal:  BMJ       Date:  1999-06-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.